4Galli M, Luciani D, Bertolini G ,et al. Lupus anticoagulants are stronger risk factors for thrombosis than antieardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood,2003,101:1827 - 1832.
5de Laat HB, Derksen RH, Urbanus RT, et al. Beta2-glycoprotein Ⅰ-dependent lupus anticoagulant highly correlates with thrombosis in the antiphospholipid syndrome. Blood ,2004,104:3598 - 3602.
6de Laat HB, Derksen RH, Urbanus RT, et al. IgG antibodies that recognize epitope Gly40-Arg43 in domain Ⅰ of beta 2-glycoprotein Ⅰ cause LAC, and their presence correlates strongly with thrombosis. Blood,2005,105 : 1540 - 1545.
8Salmon JE, de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus, 2008,17,405 - 411.
9Belizna C, Lartigue A, Favre, J. Antiphospholipid antibodies induce vascular functional changes in mice? a mechanism of vascular lesions in antiphospholipid syndrome. Lupus, 2008,17,185 - 194.
10Arbuckle MR, McClain MT, Rubertone MV,et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med ,2003,349 : 1526 - 1533.
6[1]Wilson WA, Gharavi AE,Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis & Rheumatism, 1999,42(7):1309
7[2]Lockshin MD. Pregnancy loss and antiphospholipid antibodies. Lupus, 1998, 7(Suppl 2):S86
8[3]Lie J-T.Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. Lupus, 1996, 5:368
9[4]Durrani OM, Gordon C, Murray PI, et al. Primary anti-phospholipid antibody syndrome (APS): current concepts. Surv Ophthalmol, 2002, 47(3):215
10[5]Casais P, Meschengieser SS, Gennari LC, et al. Morbidity of lupus anticoagulants in children: a single institution experience. Thrombosis Research, 2004,114:245
4Espinosa G, Cervera R. Antiphospholipid syndrome[J]. Arthritis Res Ther, 2008,10(6) :230.
5Miyakis S,Lockshin MD,Atsumi T,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome(APS)[J]. J Thromb Haemost, 2006,4(2 ) : 295-306.
6Asherson RA, Cervera R,de Groot PG,et al. Catastrophic antiphospholipid syndrome:international consensus statement on classification criteria and treatment guidelines[J]. Lupus, 2003,12(7 ) : 530-534.
7Asherson RA,Piette JC. The catastrophic antiphospholipid syndrome 1996:acute multi-organ failure associated with antiphospholipid antibodies:a review of 31 patients[J]. Lupus, 1996,5(5) :414-417.
8DEMBITZER F R,LEDFORD KRAEMER M R,MEIJER P,et al.Lupus anticoagulant testing:performance and practices by north american clinical laboratories[J].Am J Clin Pathol,2010,134:764-773.
9PASSAM F H,RAHGOZAR S,QI M,et al.Redox control ofβ2-glycoprotein I-von Willebrand factor interaction by thioredoxin-1[J].J Thromb Haemost,2010,8:1754-1762.
10XIE W,ZHANG Y,BU C,et al.Anti-coagulation effect of Fc fragment against anti-β2-GP1antibodies in mouse models with APS[J].Int Immunopharmacol,2011,11:136-140.
